CINQAIR

CINQAERO is provided as a concentrate for solution for infusion in a single-use vial.​‍​​​​​‍​‍‍‍‍​‍‍ The solution for infusion is intended only for intravenous use after dilution and should be prepared using aseptic technique as follows: Preparation of solution for infusion 1. Remove CINQAERO from the refrigerator. Do not shake the vial. 2. The medicinal product should be inspected visually before use. The concentrate is clear to slightly hazy opalescent, colourless to slightly yellow. Proteinaceous particles may be present in the concentrate that appear as translucent to white, amorphous particles, some of which may look fibrous. This is not unusual for proteinaceous solutions. The concentrate must not be used if coloured (except slightly yellow) or if foreign particles are present. 3. A suitable injection syringe should be used to withdraw the needed amount of the concentrate from the vial(s) (see section 4.2). 4. Slowly dispense the contents of the syringe(s) into an infusion bag containing 50 mL of sodium chloride 9 mg/mL (0.9%) solution for infusion. Gently invert the bag to mix the solution. This medicinal product must not be mixed with other medicinal products except sodium chloride 9 mg/mL (0.9%) solution for infusion. 5. Any concentrate remaining in the vial must be discarded. 6. It is recommended that the solution for infusion be administered immediately after preparation. Solutions of CINQAERO diluted in sodium chloride 9 mg/mL (0.9%) solution for infusion may be stored refrigerated at 2 °C-8 °C (or not above 25 °C if dilution has taken place in controlled and validated aseptic conditions), protected from light for up to 16 hours. 7. CINQAERO is compatible with polyvinylchloride (PVC) or polyolefin (PO) infusion bags. Any unused medicinal product or waste material should be disposed of in accordance with local requirements.